Marie Thibault, an analyst from BTIG, reiterated the Buy rating on Abbott Laboratories (ABT – Research Report). The associated price ...

So on that note, Abbott Laboratories (NYSE:ABT) looks quite promising in regards to its trends of return on capital. What Is Return On Capital Employed (ROCE)? Just to clarify if you're unsure ...

Abbott Laboratories showcases robust financial performance with a notable increase in net earnings. Strategic acquisitions and product launches strengthen the company's market presence.

In the last three months, 15 analysts have published ratings on Abbott Laboratories (NYSE ... a notable increase in the company's top-line earnings. When compared to others in the Health Care ...

A St. Louis jury handed Abbott Laboratories a win Thursday, deciding that Abbott, another company and a hospital were not ...

Nov 1 (Reuters) - Abbott Laboratories (ABT.N), opens new tab shares rose nearly 5% before the bell on Friday, after a jury cleared the company and a Reckitt unit of liability in a lawsuit over ...

A jury found Abbott Laboratories and Mead Johnson, owned by U.K.-based Reckitt Benckiser, not responsible for a young boy's intestinal disease, the result of a lawsuit that alleged the companies ...

In this piece, we will take a look at where Abbott Laboratories (NYSE:ABT) ranks on the list of the top UBS AI and growth era. The stock market at the tail end of 2024 is an evolution of the ...

They’re at the center of a legal battle with the makers of specialized formulas for preterm infants — north suburban-based Abbott Laboratories and Indiana-based Mead Johnson Nutrition — that ...